SCHEMBL23609342

SCHEMBL23609342

Cc1cc(NC2CCCCC2)ccc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
NR2F2 P24468 1/20 0.45
ESR2 Q92731 1/20 0.44
IDO1 P14902 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
APAF1 O14727 1/20 0.40
MAPK1 P28482 1/20 0.40
BLM P54132 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347714 0.80 FAAH (0.50)
SCHEMBL10437615 0.79 MAPT (0.49) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL11346034 0.79 RAB9A (0.59) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL3676959 0.77 RAB9A (0.49) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL16302352 0.77 RAB9A (0.58) LMNASMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL18569178 0.76 ADORA1 (0.48) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL4486171 0.76 ALDH1A1 (0.56) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL30514611 0.75 MAPT (0.44) LMNASMN1; SMN2KDM4EIDO1ALDH1A1
SCHEMBL17046021 0.75 SMN1; SMN2 (0.49) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL30910148 0.74 KDM4E (0.46) LMNASMN1; SMN2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133689-A2 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-07-01 WO disclosed